<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33637635</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>17</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>27</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Natural History of "Pure" Primary Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>e2231</StartPage><EndPage>e2238</EndPage><MedlinePgn>e2231-e2238</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000011771</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To assess whether primary lateral sclerosis (PLS), classified as pure when the EMG is normal, converts to amyotrophic lateral sclerosis (ALS) after longitudinal follow-up.</AbstractText><AbstractText Label="METHODS">Retrospective chart review was performed of patients with pure PLS at Mayo Clinic in Rochester, MN (1990-2016). Inclusion criteria required a normal EMG during the first 4 years of symptoms.</AbstractText><AbstractText Label="RESULTS">Forty-three patients had pure PLS (25 female, 58%) with a median onset age of 50 years (range 38-78 years) and median follow-up at 9 years' disease duration (range 4-36 years). The ascending paraparesis phenotype (n = 30, 70%) was most common, followed by hemiparetic onset (n = 9, 21%) and bulbar onset (n = 4, 9%). Among the 30 paraparetic-onset cases, bladder symptoms (n = 18, 60%) and dysarthria (n = 15, 50%) were more common than pseudobulbar affect (n = 9, 30%) and dysphagia (n = 8, 27%). By the last follow-up, 17 of 30 (56%) used a cane and 6 (20%) required a wheelchair. The paraparetic variant, compared with hemiparetic and bulbar onset, had the youngest onset (48 vs 56 vs 60 years, respectively; <i>p</i> = 0.02). Five patients died; 1 patient required a feeding tube; and none required permanent noninvasive ventilation. Two patients developed an idiopathic multisystem neurodegenerative disorder, which surfaced after 19 and 20 years. Two patients developed minor EMG abnormalities. The remainder 39 had persistently normal EMGs.</AbstractText><AbstractText Label="CONCLUSIONS">Pure PLS did not convert to ALS after a median of 9 years' disease duration follow-up in our study population. The ascending paraparetic phenotype was most common, with earlier onset and frequent bladder involvement. After years of pure PLS, &lt;5% develop a more pervasive neurodegenerative disorder.</AbstractText><CopyrightInformation>&#xa9; 2021 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Anhar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA. hassan.anhar@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittal</LastName><ForeName>Shivam Om</ForeName><Initials>SO</Initials><Identifier Source="ORCID">0000-0003-2138-1108</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>William T</ForeName><Initials>WT</Initials><Identifier Source="ORCID">0000-0003-4862-6777</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Josephs</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorenson</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahlskog</LastName><ForeName>J Eric</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (A.H., K.A.J., E.J.S., J.E.A.), Mayo Clinic, Rochester, MN; Department of Neurology (S.O.M.), Cleveland Clinic Abu Dhabi, United Arab Emirates; and Department of Neurology (W.T.H.), Emory University, Atlanta, GA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurology. 2021 Apr 27;96(17):783-784</RefSource><PMID Version="1">33637628</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33637635</ArticleId><ArticleId IdType="pmc">PMC8166429</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000011771</ArticleId><ArticleId IdType="pii">WNL.0000000000011771</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve 2007;35:291&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">17212349</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol 2007;64:232&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">17296839</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark FM, Moersch FP. Primary lateral sclerosis: a distinct clinical entity. J Nervous Ment Dis 1945;102:332&#x2013;337.</Citation></Reference><Reference><Citation>Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992;115:495&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">1606479</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB, et al. . The natural history of primary lateral sclerosis. Neurology 2006;66:647&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruyn RP, Koelman JH, Troost D, de Jong JM. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry 1995;58:742&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1073559</ArticleId><ArticleId IdType="pubmed">7608680</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Forestier N, Maisonobe T, Piquard A, et al. . Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 2001;124:1989&#x2013;1999.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571217</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer MA, Kojan S, Barohn RJ, et al. . Primary lateral sclerosis: clinical and laboratory features in 25 patients. J Clin Neuromuscul Dis 2005;7:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19078775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier CN, Murphy A, Loci L, et al. . Primary lateral sclerosis and early upper motor neuron disease: characteristics of a cross-sectional population. J Clin Neuromuscul Dis 2016;17:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4770823</ArticleId><ArticleId IdType="pubmed">26905909</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiser SR, Mitra D, Williams TL, Baker MR. Mills' syndrome revisited. J Neurol 2019;266:667&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6394692</ArticleId><ArticleId IdType="pubmed">30631918</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, De Marchi F, Chan J, et al. . The NEALS primary lateral sclerosis registry. Amyotroph Lateral Scler Frontotemporal Degener 2020;21:74&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">32915077</ArticleId></ArticleIdList></Reference><Reference><Citation>Schott JM, Crutch SJ, Carrasquillo MM, et al. . Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Alzheimers Dement 2016;12:862&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4982482</ArticleId><ArticleId IdType="pubmed">26993346</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, Tosakulwong N, Botha H, et al. . Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin 2020;25:102152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961761</ArticleId><ArticleId IdType="pubmed">31935638</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CF, Kakita A, Piao YS, et al. . Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol 2003;105:615&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pubmed">12734667</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Briemberg H. TDP-43 pathology in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2020;21:52&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">32657153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes PM, Turner MR, Zeidler M, Smith C, Davenport R. Progressive hemiparesis in a 75-year-old man. Pract Neurol 2015;15:63&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">25253896</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>